title: Experimental uveitis can be maintained in rabbits for a period of six weeks after a safe sensitization method.
abstract: OBJECTIVE
  New treatments against long-lasting uveitis need to be tested. Our aim was to develop a six-week model of uveitis in rabbits.
  
  
  METHODS
  Rabbits were presensitized with an s.c. injection of Mycobacterium tuberculosis H37RA emulsified with TiterMax Gold adjuvant. Uveitis was induced at day 28 and 50, by intravitreal challenges of antigen suspension. Ocular inflammation was assessed till euthanasia at day 71 after s.c. injection of M. tuberculosis H37RA by: (a) the number of inflammatory cells in aqueous humor (AH); (b) the protein concentration in AH; (c) the clinical score (mean of conjunctival hyperaemia, conjunctival chemosis, oedema and secretion); (d) the microscopical score (mean presence of fibrin and synechiae, aqueous cell density and aqueous flare grade, as scored by slit lamp).
  
  
  RESULTS
  At the sites of presensitization injection, rabbits presented flat nodules which progressively vanished. The first challenge induced a significant increase in the four parameters (p < 0.05 the Wilcoxon/Kruskal-Wallis test). The AH contained 764 ± 82 cells/µl and 32 ± 0.77 mg protein/ml. During the following days, inflammatory parameters decreased slightly. The second intravitreal challenge increased inflammation (3564 ± 228 cells/µl AH and 31 ± 1 mg protein/ml), which remained at a high level for a longer period of time.
  
  
  CONCLUSIONS
  We developed a model of long-term uveitis, which could be maintained in rabbits for at least six weeks. Such a model could be used to test the efficacy of either new drugs or various drug delivery systems intended to deliver active agents during a few months.
authors.affiliation: Jules Gonin Eye Hospital, Lausanne University, Lausanne, Switzerland. simone.eperon@fa2.ch
authors.forename: S
authors.initials: S
authors.lastname: Eperon
authors.forename: K
authors.initials: K
authors.lastname: Balaskas
authors.forename: J
authors.initials: J
authors.lastname: Vaudaux
authors.forename: Y
authors.initials: Y
authors.lastname: Guex-Crosier
mesh_terms: D000276:Adjuvants, Immunologic; D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology*; D001082:Aqueous Humor / Q000166:cytology / Q000276:immunology; D004195:Disease Models, Animal; D018450:Disease Progression; D005260:Female; D007114:Immunization; D007279:Injections, Subcutaneous; D058449:Intravitreal Injections; D011817:Rabbits; D013997:Time Factors; D014605:Uveitis / Q000175:diagnosis / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D000942:Antigens, Bacterial; C072681:Mycobacterium tuberculosis antigens